Chlorpyrifos hapten, artificial antigen, monoclonal antibody as well as preparation method and application of chlorpyrifos hapten, artificial antigen and monoclonal antibody

By developing haptens and high immunogenic artificial antigens that retain the characteristic groups of chlorpyrifos molecule, combined with monoclonal antibodies, the cost and low sensitivity of chlorpyrifos detection equipment in the prior art has been solved, and rapid and highly sensitive chlorpyrifos detection has been achieved. .

CN119019451AActive Publication Date: 2024-11-26GUANGZHOU INST FOR FOOD INSPECTION(GUANGZHOU INSPECTION CENT FOR WINE & SPIRITS) +1

Patent Information

Application Number
CN202411125029.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-15
Publication Date
2024-11-26
Estimated Expiration
2044-08-15

AI Technical Summary

Technical Problem

The prior art chlorpyrifos detection methods have the problem that equipment is expensive, the detection time is long, professional personnel are required to operate, and the on-site rapid inspection cannot be achieved. The artificial antigen prepared based on chlorpyrifos itself has poor sensitivity and low cross-reaction rate, which cannot meet market demand.

Method used

A chlorpyrifos hapten and artificial antigen was developed, and its chemical structure retained the characteristic groups of trichloro-2-pyridine and phosphorothioate in the chlorpyrifos molecule, and a highly immunogenic artificial antigen was prepared by ligating with the carrier protein. High specific monoclonal antibodies are prepared through animal immunity, which are used for colloidal gold immunochromatography technology to achieve rapid detection.

Benefits of technology

The rapid, convenient and high sensitivity detection of chlorpyrifos has been achieved, with an IC50 value of 1.25μg/L. The detection sensitivity of colloidal gold immunochromatography test strips to chlorpyrifos reaches 5μg/kg, and the sample can reach 20μg/kg, which meets the market's requirements. The need for fast and high sensitivity detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119019451A_ABST
    Figure CN119019451A_ABST
Patent Text Reader

Abstract

The invention relates to a chlorpyrifos hapten, an artificial antigen, a monoclonal antibody and a preparation method and application thereof, the chemical structural formula of the chlorpyrifos hapten is # imgabs0 #, and the preparation method comprises the following steps: reacting 3, 5, 6-trichloropyridine-2-ol with ethyl thiophosphoryl dichloride to obtain a compound c; reacting the compound c with 3-hydroxy-2-(hydroxymethyl) ethyl propionate to obtain a compound e; and hydrolyzing the compound e under an alkaline condition to obtain the chlorpyrifos hapten. According to the chlorpyrifos hapten disclosed by the invention, each molecule contains two complete chlorpyrifos structures, and characteristic groups of trichloro-2-pyridine and thiophosphate in the chlorpyrifos molecule can be completely reserved, so that the electron cloud density between the prepared hapten and an original drug is consistent; meanwhile, the prepared artificial antigen also enables small molecules to have a more prominent space structure in carrier protein, and the immunogenicity of the antigen is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of food safety, and in particular to a chlorpyrifos hapten, an artificial antigen, a monoclonal antibody, and a preparation method and application thereof. Background Art

[0002] Chlorpyrifos, chemical name O,O-diethyl-O-(3,5,6-trichloro-2-pyridyl)phosphorothioate, molecular formula C9H 11 Cl3NO3PS is a white crystal with a slight thiol smell. It is a non-systemic broad-spectrum insecticide and acaricide. It is currently widely used in agricultural production. It is one of the new high-efficiency and low-toxic alternatives to highly toxic pesticides such as methyl parathion and methyl parathion. It is also an important variety for monitoring pesticide residues in safe agricultural products. As the situation of chlorpyrifos residues in the environment becomes more and more serious, it poses a huge threat to people's health. "GB 2763-2021 Maximum Residue Limits of Pesticides in Foods" stipulates that the maximum residue limit standard (MRL) of chlorpyrifos in edible peas is 0.01 mg / kg, and the minimum maximum residue limit standard (MRL) in other fruits and vegetables is 0.02 mg / kg.

[0003] Among the relevant detection technologies, the detection method of chlorpyrifos is mainly based on instrumentation. However, due to the high cost of the required equipment and instruments, the long detection time, and the need for professional personnel to operate, it is impossible to truly achieve on-site detection and rapid inspection, which brings great inconvenience to daily detection work.

[0004] The key to immunoassay detection technology is determined by the performance of antigens and antibodies, and the key to antigens and antibodies is haptens. Therefore, in order to obtain antigens and antibodies with excellent performance, the structural design of haptens is particularly important. In the related technology, artificial antigens directly prepared based on chlorpyrifos itself have the defects of poor sensitivity and low cross-reaction rate, which cannot meet the actual use needs of the existing market. Therefore, the development of highly specific chlorpyrifos haptens or artificial antigens is of vital importance for a rapid, highly sensitive and low-cost detection method for chlorpyrifos. Summary of the invention

[0005] Technical problem to be solved: In view of the shortcomings of the prior art, the present invention provides a chlorpyrifos hapten, an artificial antigen, a monoclonal antibody and a preparation method and application thereof. The chlorpyrifos hapten not only contains two complete chlorpyrifos structures in each molecule, but also the characteristic groups of trichloro-2-pyridine and phosphorothioate in the chlorpyrifos molecule can be completely retained, so that the electron cloud density between the prepared hapten and the original drug is the same; at the same time, the prepared artificial antigen also enables the small molecule to have a more prominent spatial structure in the carrier protein, thereby improving the immunogenicity of the antigen.

[0006] Technical solution: A chlorpyrifos hapten, the chemical structure of the chlorpyrifos hapten is:

[0007]

[0008] The above-mentioned method for preparing a chlorpyrifos hapten comprises the following steps:

[0009] 1) Compound a and compound b react to obtain compound c, wherein compound a is 3,5,6-trichloropyridine-2-ol, compound b is ethylthiophosphoryl dichloride, and the structural formula of compound c is

[0010] 2) Compound c reacts with compound d to obtain compound e, wherein compound d is ethyl 3-hydroxy-2-(hydroxymethyl)propionate, and the structural formula of compound e is

[0011] 3) Compound e is hydrolyzed under alkaline conditions to obtain chlorpyrifos hapten.

[0012] A chlorpyrifos artificial antigen, which is obtained by connecting the chlorpyrifos hapten and a protein carrier, and the chemical structure of the chlorpyrifos artificial antigen is:

[0013]

[0014] Among them, protein is a protein carrier.

[0015] The protein carrier described above is bovine serum albumin, lactoferrin, ovalbumin, human serum albumin or hemocyanin.

[0016] A chlorpyrifos monoclonal antibody is prepared by immunizing animals with the chlorpyrifos artificial antigen.

[0017] Application of the above-mentioned chlorpyrifos artificial antigen and the above-mentioned chlorpyrifos monoclonal antibody in the preparation of a chlorpyrifos detection kit.

[0018] The use of the above-mentioned chlorpyrifos artificial antigen and chlorpyrifos monoclonal antibody in the preparation of a chlorpyrifos detection kit, the detection kit comprises a chlorpyrifos colloidal gold immunochromatographic test strip, the T line of the chlorpyrifos colloidal gold immunochromatographic test strip is coated with the chlorpyrifos artificial antigen, and the C line is coated with the chlorpyrifos monoclonal antibody.

[0019] Beneficial effects: The chlorpyrifos hapten, artificial antigen, monoclonal antibody and preparation method and application thereof provided by the present invention have the following beneficial effects:

[0020] 1. The hapten prepared by the present invention not only contains two complete chlorpyrifos structures in each molecule, but also the characteristic groups of trichloro-2-pyridine and phosphorothioate in the chlorpyrifos molecule can be completely retained, so that the electron cloud density between the prepared hapten and the original drug is the same; at the same time, the prepared artificial antigen also enables the small molecule to have a more prominent spatial structure in the carrier protein, thereby improving the immunogenicity of the antigen.

[0021] 2. The chlorpyrifos artificial antigen and monoclonal antibody of the present invention are highly specific for ELISA detection, with an IC50 value of 1.25 μg / L.

[0022] 3. The artificial chlorpyrifos antigen and monoclonal antibody of the present invention are used in colloidal gold immunochromatography technology to quickly and conveniently realize the qualitative detection of chlorpyrifos.

[0023] 4. The colloidal gold immunochromatographic test strip prepared in the present invention has a sensitivity of 5 μg / kg for chlorpyrifos in a standard solution, and a detection sensitivity of up to 20 μg / kg in a sample. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 is the synthesis reaction equation of the chlorpyrifos hapten in Example 1.

[0025] Figure 2 This is the mass spectrum of the chlorpyrifos hapten in Example 1.

[0026] Figure 3 This is the synthetic reaction equation for the chlorpyrifos artificial antigen of Example 2.

[0027] Figure 4 The standard curve was drawn by using the ELISA Calc software to fit the four-parameter logistic curve in Example 3.

[0028] Figure 5 This is a standard diagram for visual judgment of the colloidal gold immunochromatographic test paper card for chlorpyrifos in Example 4. DETAILED DESCRIPTION

[0029] The experimental methods described in the following examples are conventional methods unless otherwise specified; the reagents and biological materials described are available from commercial channels unless otherwise specified.

[0030] Example 1

[0031] This embodiment provides a chlorpyrifos hapten, and the chemical structure of the chlorpyrifos hapten is:

[0032]

[0033] The synthesis reaction equation of the chlorpyrifos hapten is as follows Figure 1 shown.

[0034] The preparation steps of the chlorpyrifos hapten are as follows:

[0035] (1) 11.09 g (55.87 mmol, CAS: 37439-34-2) of compound a was placed in a 100 mL round-bottom flask, and 20 mL of tetrahydrofuran and 3.58 g (11.18 mmol) of K2CO3 were added in sequence. After being stirred thoroughly, the temperature was raised to 50-60°C. At the same temperature, a mixture of 1.00 g (5.59 mmol, CAS: 1498-64-2) of compound b dissolved in 20 mL of tetrahydrofuran was slowly added dropwise. After the addition was complete, the reaction mixture was reacted at 50-60°C for more than 3-4 h. After the reaction was completed, the solvent was evaporated under reduced pressure, 100 mL of purified water was added to the residue, and the mixture was extracted twice with ethyl acetate. The organic phase was desolventized, and the residue was purified by column chromatography (30% EA / PE, V / V) to obtain 1.22 g of compound c.

[0036] (2) 1.22 g (3.58 mmol) of compound c was added to 10 mL of tetrahydrofuran solution, and then 0.25 g (1.72 mmol, CAS: 99116-11-7) of compound d and 0.43 g (4.29 mmol) of triethylamine were added in sequence, and the reaction mixture was reacted at 40-50° C. for 2-3 h. After the reaction was completed, the solvent was evaporated under reduced pressure, 50 mL of purified water was added to the residue, and the mixture was extracted twice with ethyl acetate. The organic phase was desolventized, and the residue was purified by column chromatography (20% EA / PE, V / V) to obtain 0.64 g of compound e.

[0037] (3) 0.64 g (0.85 mmol) of compound e was dissolved in 10 mL of ethanol, and then 10 mL of 6 mol / L lithium hydroxide aqueous solution was added. The resulting reaction mixture was reacted at room temperature for 10 to 12 h, 30 mL of saturated sodium chloride aqueous solution was added, and extracted twice with 30 mL of dichloromethane. The aqueous phase was collected, and the pH value was adjusted to 4 to 5 with 4 mol / L hydrochloric acid. The solid precipitated, filtered, and dried to obtain 0.36 g of chlorpyrifos hapten (i.e. Figure 1 Chinese formula 1 hapten).

[0038] The mass spectrum of the chlorpyrifos hapten (ESI-MS: 726.8 [M-1]) is as follows: Figure 2 shown.

[0039] Example 2

[0040] This embodiment provides a chlorpyrifos artificial antigen, and the chemical structure of the chlorpyrifos artificial antigen is:

[0041]

[0042] Among them, protein is a protein carrier.

[0043] The protein carrier is bovine serum albumin, lactoferrin, ovalbumin, human serum albumin or hemocyanin.

[0044] The synthetic reaction equation of the chlorpyrifos artificial antigen is as follows: Figure 3 shown.

[0045] The steps for preparing the chlorpyrifos artificial antigen with bovine serum albumin as carrier protein are as follows:

[0046] (1) 10 mg of the chlorpyrifos hapten prepared in Example 1 was dissolved in 0.2 mL of dimethylformamide (DMF), and after sufficient stirring, 10 mg of EDC and 10 mg of N-hydroxysuccinimide (NHS) were added, and the mixture was stirred at room temperature for 4 h to obtain a hapten activated ester;

[0047] (2) Weigh 40 mg of bovine serum albumin (BSA) and fully dissolve it in 4 mL of 0.01 mol / L PBS solution to form a carrier protein solution. Slowly add the hapten activated ester in step (1) dropwise into the carrier protein solution under stirring, and stir at room temperature for 16 to 24 hours.

[0048] (3) The solution obtained in step (2) was dialyzed with 0.01 mol / L PBS at room temperature for 3 days, and the dialysate was changed 3 times a day to remove unreacted small molecules;

[0049] (4) Aliquot and store at 4°C until needed.

[0050] The steps for preparing the chlorpyrifos artificial antigen with lactoferrin as carrier protein are as follows:

[0051] (1) 5 mg of the chlorpyrifos hapten prepared in Example 1 was dissolved in 0.1 mL of dimethylformamide (DMF), and after sufficient stirring, 5 mg of EDC and 5 mg of N-hydroxysuccinimide (NHS) were added, and the mixture was stirred at room temperature for 4 h to obtain a hapten activated ester;

[0052] (2) Weigh 30 mg of lactoferrin (LF) and fully dissolve it in 5 mL of 0.01 mol / L PBS solution to form a carrier protein solution. Slowly add the hapten activated ester dropwise into the carrier protein solution under stirring, and stir at room temperature for 16 to 24 hours.

[0053] (3) The solution obtained in step (2) was dialyzed with 0.01 mol / L PBS at room temperature for 3 days, and the dialysate was changed 3 times a day to remove unreacted small molecules;

[0054] (4) Aliquot and store at 4°C until needed.

[0055] Example 3

[0056] This example provides a method for preparing a chlorpyrifos monoclonal antibody, and the preparation steps are as follows:

[0057] The above-mentioned carrier protein is lactoferrin, and the artificial antigen of chlorpyrifos is used as the immunogen. After being emulsified with an equal volume of Freund's adjuvant, BALB / C mice are immunized. The immunization dose for each mouse is 50-100 μg, and the immunization interval is 2 weeks. After immunization 3 times, the tail venous blood of the mouse is collected to detect the serum titer. If the antibody titer does not meet the requirements, it is necessary to strengthen the immunization. After the antibody titer no longer increases, 100 μg of full antigen is used for subcutaneous strengthening immunization. After 5 days, the mouse spleen cells are taken and fused with SP20 cells. The fused cells are screened in HAT culture medium, and the complete culture medium is replaced with HAT culture medium for culture after 5 days. The cell supernatant is detected by ELISA, and the cells in the wells with strong positive test results are cloned and cultured by limiting dilution method. After 3 clone culture tests, the cells in the wells that are positive are hybridoma cells that secrete monoclonal antibodies. After the hybridoma cells are amplified and cultured, they are inoculated into the peritoneal cavity of mice to produce ascites containing antibodies. By purifying ascites with the caprylic acid-ammonium sulfate precipitation method, high-purity and high-specificity chlorpyrifos monoclonal antibodies can be obtained.

[0058] The application and effect of the chlorpyrifos artificial antigen prepared in Example 2 and the chlorpyrifos monoclonal antibody prepared in Example 3 in ELISA were evaluated. The specific process and results are shown below.

[0059] Using carbonate buffer at pH 9.6 as coating diluent, the chlorpyrifos artificial antigen with bovine serum albumin as carrier protein was diluted to 0.05 μg / mL, and added to the polystyrene microplate at 100 μL / well, coated overnight at 4°C, dried, and added to 1% BSA / phosphate buffer at 280 μL / well at 37°C for blocking for 1 hour, dried, and vacuum packed for storage after drying.

[0060] The chlorpyrifos monoclonal antibody was diluted to 0.1 μg / mL using phosphate buffer containing 0.05% sodium azide and pH 7.4 and stored at 4°C for later use.

[0061] The chlorpyrifos standard was dissolved in 0.01 M PBS buffer and the concentrations were respectively 0, 0.3, 0.9, 2.7, 8.1 and 27.3 μg / L to obtain chlorpyrifos standard solutions.

[0062] 100 μL / well of chlorpyrifos standard solution was added to the microwell ELISA plate coated with chlorpyrifos artificial antigen, and then 20 μL / well of chlorpyrifos monoclonal antibody solution was added accordingly, and the reaction was carried out at 37°C for 0.5h; after drying, 280 μL / well of PBST washing solution was added, and the plate was washed 3 times and patted dry; then 100 μL / well of enzyme-labeled secondary antibody was added, and the reaction was carried out at 37°C for 0.5h; after washing 3 times again and patting dry, 50 μL / well of TMB color developing solution A and TMB color developing solution B were added respectively, and the reaction was carried out at 37°C for 15min; 50 μL / well of 1 mol / L sulfuric acid was added to terminate the reaction, and the OD value of each well was measured by setting the ELISA reader at a wavelength of 450 nm. The results are shown in Table 1 below.

[0063] Table 1

[0064] Concentration (μg / L) 0 0.3 0.9 2.7 8.1 27.3 OD value (chlorpyrifos) 1.72 1.47 0.99 0.58 0.38 0.29

[0065] From the data in Table 1, we can see that the four-parameter Logistic curve fitting was performed using ELISACalc software to draw the standard curve (such as Figure 4 The linear equation of chlorpyrifos is:

[0066] y=(AD) / [1+(x / C)^B]+D,

[0067] Among them, r 2 =0.99916, A=1.72696, B=1.30385, C=0.90769, D=0.28733, x represents the concentration of the analyte, y represents the OD value, and the IC50 value obtained by calculation is 1.25μg / L, which is linear in the range of 0.2-6.4μg / L.

[0068] Example 4

[0069] This embodiment provides a method for preparing a chlorpyrifos colloidal gold immunochromatographic test paper card, and the preparation steps are as follows:

[0070] (1) Preparation of reaction membrane coated with artificial antigen and mouse IgG:

[0071] A nitrocellulose membrane (NC membrane) is used as a reaction membrane, an artificial antigen whose carrier protein is bovine serum albumin is adjusted to a concentration of 0.05-0.2 mg / mL with a coating buffer, and a mouse IGg is also adjusted to a concentration of 0.1-0.5 mg / mL with a coating buffer, and the antigen and mouse IGg are sprayed onto the detection area (T line) and control area (C line) corresponding to the reaction membrane according to a membrane liquid volume of 0.8-1.2 μL / cm, with an interval of 2.5 mm between the detection area and the control area, placed in a 45° C. oven for 12-16 hours, and placed in a constant temperature and humidity storage box for use, and the coating buffer used is a PBS buffer containing 1% sucrose and 0.05% sodium azide, a pH value of 7.6, and a concentration of 0.01 mol / L;

[0072] (2) Preparation of nano-gold labeled chlorpyrifos monoclonal antibody micropores:

[0073] 1. Preparation of nanogold solution:

[0074] Take 1g of chloroauric acid, dissolve it with pure water and ultrasound, and then make up to 100mL. Store it at 4℃ away from light for later use. Take 2mL of the above solution to 100mL of pure water, heat it to boiling, then add 0.5mL of 0.06% sodium citrate solution, continue heating for 10min, cool it to room temperature, restore it to the original volume with pure water, and store it at room temperature away from light for later use to obtain the nano gold solution. All glassware used must be soaked in a mixture of potassium permanganate and sulfuric acid overnight, and then washed and dried before use.

[0075] 2. Labeling of chlorpyrifos monoclonal antibody:

[0076] Dispense 1mL / bottle of nanogold solution and adjust the pH value of the nanogold solution with 0.1mol / L K2 CO3. Add 3μg of chlorpyrifos monoclonal antibody to the nanogold solutions of different pH values ​​and react at room temperature for 5min. Observe the color change of the solution and record the pH value that keeps the solution red. Add 10μl of 10% bovine serum albumin for blocking, centrifuge at 12,000rpm for 10min, and discard all the clear liquid.

[0077] 3. Preparation of micropores:

[0078] Add 1 mL of gold diluent to re-dissolve, dispense 12 μL / well into microwells, dry at 37°C for 16 h, and store for later use.

[0079] The gold diluent used was 0.01 mol / L PBST buffer containing 2% Tris, 2% bovine serum albumin, 0.05% thimerosal, and 5% sucrose.

[0080] (3) Preparation of sample pad:

[0081] Soak the cut 30*30cm blank sample pad in the sample treatment solution for 5 minutes, take it out and dry it at 37℃ for 16 hours, and place it in a constant temperature and humidity storage box for use. The sample pad treatment solution used is 0.01mol / L PBST buffer containing 0.3% Tween 20, 1% sucrose, 0.5% Triton 405, and 0.05% sodium azide.

[0082] (4) Assembly of chlorpyrifos colloidal gold immunochromatographic test paper card:

[0083] The reaction membrane prepared in step (1) is stacked on the middle of the PVC board backing, and the sample pad and the water-absorbing pad prepared in step (3) are stacked on both ends. The reaction membrane is connected to the water-absorbing pad and the sample pad respectively, and the detection area is close to the sample pad and the control area is close to the water-absorbing pad to obtain a test paper. The test paper is cut into 3 mm test strips, and the test strips are loaded into the test paper card to obtain a chlorpyrifos colloidal gold immunochromatographic test paper card.

[0084] The performance of the chlorpyrifos colloidal gold immunochromatographic test paper card prepared in Example 4 was evaluated, and the specific process and results are shown below.

[0085] A series of chlorpyrifos standard solutions of different concentrations were prepared with 0.01 mol / L PBS buffer, and then 100 μL of the standard solution was added to the gold-labeled microwells, and the solution was repeatedly blown to make it uniformly redissolved. After standing for 5 minutes, the solution in the gold-labeled microwells was transferred to the sample addition well of the chlorpyrifos colloidal gold immunochromatography card of the present invention, and the timing was started after the sample was added. The results can be observed in 5 to 8 minutes, and it is judged to be invalid after 8 minutes.

[0086] Visual interpretation method: If the color of T line is stronger than that of C line or there is no significant difference with that of C line, it indicates a negative test result (-). If the color of T line is significantly weaker than that of C line or T line does not show color, it indicates a positive test result (+). Invalid: No C line appears, indicating an incorrect operation process or the test strip has expired. The test is repeated for 3 groups to achieve rapid qualitative detection of chlorpyrifos colloidal gold immunochromatographic test strips. The judgment criteria are as follows: Figure 5 shown.

[0087] The determination results of chlorpyrifos standard solutions at different concentrations are shown in Table 2 below.

[0088] Table 2

[0089]

[0090] It can be seen from Table 2 that, by detecting the concentration value of the chlorpyrifos standard solution, the colloidal gold immunochromatographic reagent card prepared in the present invention has a high sensitivity for chlorpyrifos detection, which can reach 5 μg / L.

[0091] The stability of the chlorpyrifos colloidal gold immunochromatographic test paper card prepared in Example 4 was tested, and the specific process and results are shown below.

[0092] The chlorpyrifos colloidal gold immunochromatographic test strip card was stored at room temperature. In order to ensure the stability of the test strip, the test strip was subjected to an accelerated destructive test. It was placed at room temperature and 54°C for 60 consecutive days, and the negative and chlorpyrifos standard solution color changes were detected on the 0th day, the 5th day, the 10th day, the 20th day, the 30th day, the 40th day, the 50th day and the 60th day, respectively. The experiment was repeated for 3 groups, and the results are shown in Table 3 below: ("+" represents positive, "-" represents negative)

[0093] Table 3

[0094]

[0095] As shown in Table 3, after 60 days of sealed colloidal gold qualitative immunochromatographic test strips stored at room temperature and 37°C, the T / C color depth interpretation results of the test strips did not change significantly, indicating that the colloidal gold qualitative immunochromatographic test strips can be stably stored for at least 60 days at 37°C in an accelerated experiment. Therefore, the chlorpyrifos colloidal gold immunochromatographic test paper card prepared by the present invention can be stably stored at room temperature for more than one year, which can fully meet the market requirements during storage and transportation.

[0096] The detection performance of the chlorpyrifos colloidal gold immunochromatographic test paper card prepared in Example 4 on fruit and vegetable samples was tested, and the specific process and results are shown below.

[0097] Take 2g of fruit and vegetable samples (4g for tubers), cut leafy vegetables into pieces of about 1cm square, take cross-section samples or take the epidermis of tubers, put them into a 50mL centrifuge tube, add 7mL of 0.01mol / L PB buffer, shake vigorously and mix for 2min, let the centrifuge tube stand for 2min, and the supernatant is the test solution. If the diluent is turbid or there are too many impurities, filter it (or centrifuge at 4000 rpm for 3min) and then test it. Before testing, use a centrifuge tube to dilute the sample solution and diluent in different proportions to obtain the test solution.

[0098] Take 100 μL of the test solution and add it to the sample addition hole of the colloidal gold immunochromatography card of the present invention. Start timing after adding the sample, and observe the results according to the schematic diagram for 5 to 8 minutes. Visual interpretation method: The color of the T line is stronger than the color of the C line or there is no obvious difference with the color of the C line, indicating that the sample is negative (-). Positive (+): The color of the T line is significantly weaker than the color of the C line or the T line does not color, indicating that the sample is positive (+). Invalid: The C line does not appear, indicating an incorrect operation process or the test strip has expired.

[0099] Minimum detection limit: The chlorpyrifos standard was dissolved in methanol and a certain amount was added to the sample according to the spike requirement so that its concentration in the sample was 0, 10, 20, 40, and 80 μg / kg, respectively. The results are shown in Table 4.

[0100] Table 4

[0101]

[0102]

[0103] As shown in Table 4 above, the chlorpyrifos colloidal gold immunochromatographic test paper prepared by the present invention has good repeatability in the test results of 10 samples. When the chlorpyrifos content in the sample is lower than 20 μg / kg, all are negative; when it is higher than 20 μg / kg, all are positive. Therefore, the detection limit of the chlorpyrifos colloidal gold immunochromatographic reagent card prepared by the present invention in the sample is 20 μg / kg.

[0104] The embodiments of the present invention are described in detail above. For those skilled in the art, according to the ideas of the embodiments of the present invention, there may be changes in the specific implementation methods and application scopes. In summary, the content of this specification should not be understood as limiting the present invention.

Claims

1. A chlorpyrifos hapten, characterized in that The chemical structural formula of the chlorpyrifos hapten is:

2. The method for preparing a chlorpyrifos hapten according to claim 1, characterized in that The preparation steps are as follows: 1) Compound a and compound b react to obtain compound c, wherein compound a is 3,5,6-trichloropyridine-2-ol, compound b is ethylthiophosphoryl dichloride, and the structural formula of compound c is 2) Compound c reacts with compound d to obtain compound e, wherein compound d is ethyl 3-hydroxy-2-(hydroxymethyl)propionate, and the structural formula of compound e is 3) Compound e is hydrolyzed under alkaline conditions to obtain chlorpyrifos hapten.

3. An artificial chlorpyrifos antigen, characterized in that: The chlorpyrifos artificial antigen is obtained by connecting the chlorpyrifos hapten and a protein carrier. The chemical structure of the chlorpyrifos artificial antigen is: Among them, protein is a protein carrier.

4. The artificial chlorpyrifos antigen according to claim 3, characterized in that: The protein carrier is bovine serum albumin, lactoferrin, ovalbumin, human serum albumin or hemocyanin.

5. A chlorpyrifos monoclonal antibody, characterized in that: The chlorpyrifos monoclonal antibody is prepared by immunizing animals with the chlorpyrifos artificial antigen.

6. Use of the chlorpyrifos artificial antigen according to claim 3 or 4 and the chlorpyrifos monoclonal antibody according to claim 5 in the preparation of a chlorpyrifos detection kit.

7. Use of the chlorpyrifos artificial antigen and chlorpyrifos monoclonal antibody according to claim 6 in the preparation of a chlorpyrifos detection kit, characterized in that: The detection kit comprises a chlorpyrifos colloidal gold immunochromatographic test strip, wherein the T line of the chlorpyrifos colloidal gold immunochromatographic test strip is coated with the chlorpyrifos artificial antigen, and the C line is coated with the chlorpyrifos monoclonal antibody.

Citation Information

Patent Citations

  • Chlorpyrifos hapten, chlorpyrifos holoantigen and preparation methods of chlorpyrifos hapten and chlorpyrifos holoantigen

    CN103172674A

  • Nicarbazin hapten, nicarbazin artificial antigen and preparation method and application thereof

    CN117402087A

Cited By

  • Chlorpyrifos hapten, artificial antigen, preparation method and application thereof

    CN122749602A